People news: Pfizer, Epocrates, GCI and Spectrum

Share this article:
Mobile reference firm Epocrates appointed former Pfizer executive Peter Brandt to its board of directors. Brandt will join the board's audit and compensation committees and is expected to provide strategic direction on Epocrates' interactive services for the healthcare industry. Brandt held leadership positions at Pfizer for two decades, ultimately serving as president of its US pharma business. He also led Pfizer Health Solutions, a clinical technology unit.

GCI Health named Elisia Canna director of consumer health, reporting to CEO Wendy Lund. Canna joins GCI from Porter Novelli, where she was EVP deputy general manager of the New York health practice and led the launches of Nicorette, NicoDerm CQ and Commit Lozenge, along with the Great American Smokeout.

Spectrum rehired Lissette Capati as VP. Capati returns to the agency from Zeno Group, where she led corporate and scientific communications and social media campaigns for clients in the company's health care practice.
Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.